← FDA DRUG APPROVALS

FDA ANDA · ANDA062560

MANDOL

Sponsor: LILLY

APPLICATION
ANDA062560
TYPE
ANDA
ORIGINAL APPROVAL
1985-09-10
LATEST ACTION
2007-12-07
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

MANDOLDiscontinued
CEFAMANDOLE NAFATE EQ 1GM BASE/VIAL · INJECTABLE · INJECTION
MANDOLDiscontinued
CEFAMANDOLE NAFATE EQ 2GM BASE/VIAL · INJECTABLE · INJECTION

Approval history

2007-12-07Labeling · Supplement 3AP
2007-12-07Labeling · Supplement 2AP
1992-11-23Manufacturing (CMC) · Supplement 4AP
1992-10-30Manufacturing (CMC) · Supplement 5AP
1985-09-10OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →